The seventh annual Biotech Showcase™ investor conference wrapped up the week of January 12 in San Francisco with the highest number of delegates in attendance since its founding.
More than 2,100 executive-level delegates representing qualified private and public equity investors, industry analysts, bankers, pharmaceutical and biotechnology industry executives attended from 1,287 companies and participated in nearly 4,300 one-to-one investor meetings.
“The positive feedback we have received about Biotech Showcase 2015 is clear evidence that it is considered a must-attend meeting by biotech, pharma, and investors and other industry executives every January,” said Sara Jane Demy, CEO of Demy-Colton Life Science Advisors. “The caliber and variety of investors this year is unmatched by previous editions of Biotech Showcase which is a testament to the buoyancy of the current market.”
“This year we had a stellar list of 232 public and private biotech presenting companies with numerous investment opportunities,” said Anna Chrisman, Group Managing Director, EBD Group. “The market is up and there is significant activity, which makes Biotech Showcase very compelling for life sciences companies looking for investors and partners.”
Biotech Showcase is powered by partneringONE®, the industry’s most advanced meeting system that enables delegates to efficiently identify and arrange meetings with potential investors.
Up-to-date coverage of Biotech Showcase, including panel videos and interviews, can be found on the Biotech Showcase website, on partnering360:Insight, and on the partnering360 Blog.
The next edition of Biotech Showcase will be held January 11–13, 2016 in San Francisco.